• Explore /
  • Poster
  • / PROSPER: Phase III randomized study comparing perioperative nivolumab versus observation in patients with renal cell carcinoma (RCC) undergoing nephrectomy (ECOG-ACRIN EA8143).

PROSPER: Phase III randomized study comparing perioperative nivolumab versus observation in patients with renal cell carcinoma (RCC) undergoing nephrectomy (ECOG-ACRIN EA8143).

Abstract Video & Slides Poster

Authors

null

Naomi B. Haas

Abramson Cancer Ctr, Philadelphia, PA

Naomi B. Haas , Maneka Puligandla , Mohamad E. Allaf , David F. McDermott , Charles G. Drake , Sabina Signoretti , David Cella , Rajan T. Gupta , Brian M. Shuch , Primo Lara Jr., Anil Kapoor , Daniel Yick Chin Heng , Bradley C. Leibovich , M Dror Michaelson , Toni K. Choueiri , Michael A.S. Jewett , Deb Maskens , Lauren C Harshman , Viraj A. Master , Michael Anthony Carducci

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2020 ASCO Virtual Scientific Program

Session Type

Poster Session

Session Title

Genitourinary Cancer—Kidney and Bladder

Track

Genitourinary Cancer—Kidney and Bladder

Sub Track

Kidney Cancer

Clinical Trial Registration Number

NCT03055013

Citation

J Clin Oncol 38: 2020 (suppl; abstr TPS5101)

DOI

10.1200/JCO.2020.38.15_suppl.TPS5101

Abstract #

TPS5101

Poster Bd #

170

Abstract Disclosures

Similar Posters

First Author: Lauren Christine Harshman

First Author: Lauren Christine Harshman

First Author: Lauren Christine Harshman

First Author: Mohamad E. Allaf